Showing 13 to 16 of 16 results
Record Stem Cell Donations in Netherlands, but Future Growth Uncertain
A record 285 Dutch citizens donated stem cells in 2023, aiding patients with leukemia; including German donations, the total reached 323, yet the annual donor increase lags behind the desired rate, raising concerns for the future.
Record Stem Cell Donations in Netherlands, but Future Growth Uncertain
A record 285 Dutch citizens donated stem cells in 2023, aiding patients with leukemia; including German donations, the total reached 323, yet the annual donor increase lags behind the desired rate, raising concerns for the future.
Progress
36% Bias Score
Record Stem Cell Donations in Netherlands: Successes and Future Challenges
A record 285 Dutch citizens donated stem cells in 2023, aided by a decade-long increase in registered donors, to treat 9000 annual leukemia diagnoses; however, slower growth and an aging donor pool pose future challenges.
Record Stem Cell Donations in Netherlands: Successes and Future Challenges
A record 285 Dutch citizens donated stem cells in 2023, aided by a decade-long increase in registered donors, to treat 9000 annual leukemia diagnoses; however, slower growth and an aging donor pool pose future challenges.
Progress
32% Bias Score
Record Stem Cell Donations in Netherlands, but Future Growth Uncertain
In 2023, 285 Dutch citizens (323 including Germany) donated stem cells, a record high, to treat leukemia patients; this follows a decade-long increase in registrations but growth is slower than desired due to the 55-year age limit.
Record Stem Cell Donations in Netherlands, but Future Growth Uncertain
In 2023, 285 Dutch citizens (323 including Germany) donated stem cells, a record high, to treat leukemia patients; this follows a decade-long increase in registrations but growth is slower than desired due to the 55-year age limit.
Progress
32% Bias Score
€400,000 Grant Funds Multi-Omic Leukemia Therapy Research at University of Parma
The University of Parma's Translational Hematology and Chemogenomics group received a €400,000 grant to develop personalized therapies for high-risk acute leukemias using a multi-omic model integrating genomic, proteomic, and metabolic data, led by Giovanni Roti in collaboration with Alessio Lodola.
€400,000 Grant Funds Multi-Omic Leukemia Therapy Research at University of Parma
The University of Parma's Translational Hematology and Chemogenomics group received a €400,000 grant to develop personalized therapies for high-risk acute leukemias using a multi-omic model integrating genomic, proteomic, and metabolic data, led by Giovanni Roti in collaboration with Alessio Lodola.
Progress
8% Bias Score
Showing 13 to 16 of 16 results